SEC Form 5 · accession 0001209191-18-009234
Biohaven Pharmaceutical Holding Co Ltd. · BHVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vlad Coric
Officer — Chief Executive Officer · Director
Period of report
Dec 31, 2017
Accepted (ET)
Feb 12, 2018 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001689813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Nov 30, 2017 | G | 25,000 | $0.00 | D | 550,000 | I | By The Vladimir Coric Family Trust 2013 |
| Common Shares | Nov 30, 2017 | G | 25,000 | $0.00 | D | 550,000 | I | By The Vladimir Coric Marital Trust 2013 |
Table II — derivative securities
No Table II lines on this filing.